Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
00:33:56 EDT Sun 05 May 2024
Enter Symbol
or Name
USA
CA



News for U:KOD from 2023-05-04 to 2024-05-03 - 16 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-05-02 16:30U:KODNews ReleaseKodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform
2024-03-28 06:30U:KODNews ReleaseKodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
2024-03-26 06:15U:KODNews ReleaseKodiak Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results and Host Business Updates Webcast on March 28, 2024
2024-01-30 06:30U:KODNews ReleaseKodiak Sciences Announces Upcoming Presentation of First Time Results of KSI-501ABC Phase 1 Study at the Angiogenesis, Exudation, and Degeneration 2024 Virtual Meeting
2024-01-04 16:15U:KODNews ReleaseKodiak Sciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
2023-11-21 16:15U:KODNews ReleaseKodiak Sciences to Present at the 6th Annual Evercore ISI HealthCONx Conference
2023-11-14 16:01U:KODNews ReleaseKodiak Sciences Announces Third Quarter 2023 Financial Results and Recent Business Highlights
2023-11-06 05:00U:KODNews ReleaseKodiak reboots tarcocimab tedromer development program following strong positive results in Phase 3 diabetic retinopathy GLOW study and following dialogue with US regulatory authorities on a regulatory pathway for BLA submission
2023-11-01 23:21U:KODNews ReleaseKODIAK SCIENCES ANNOUNCES FIRST TIME PRESENTATION OF PRIMARY ENDPOINT DATA FROM TARCOCIMAB TEDROMER PHASE 3 GLOW STUDY IN PATIENTS WITH DIABETIC RETINOPATHY AT AMERICAN ACADEMY OF OPHTHALMOLOGY ANNUAL MEETING
2023-10-11 06:00U:KODNews ReleaseKodiak Sciences Announces Upcoming Presentations at the 56th Annual Scientific Meeting of the Retina Society
2023-09-08 06:00U:KODNews ReleaseKodiak Sciences to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
2023-09-07 06:00U:KODNews ReleaseNew one-year results for Kodiak's tarcocimab tedromer in the pivotal BEACON trial reinforce durability signal and demonstrate matched efficacy and comparable safety and tolerability in retinal vein occlusion
2023-08-14 16:01U:KODNews ReleaseKodiak Sciences Announces Second Quarter 2023 Financial Results and Recent Business Highlights
2023-07-24 06:00U:KODNews ReleaseKodiak Sciences Announces Topline Results from its Phase 3 Studies of Tarcocimab Tedromer in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema and Provides Update on Tarcocimab Development Program
2023-05-30 16:15U:KODNews ReleaseKodiak Sciences to Present at Upcoming Investor Conferences
2023-05-15 16:01U:KODNews ReleaseKodiak Sciences Announces First Quarter 2023 Financial Results and Recent Business Highlights